Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

Insiders Buy Shares at Achillion Pharmaceuticals, Inc. and China Cord Blood

By

Plus, there were two purchases at Digirad.

PrintPRINT
Welcome to our daily roundup of top insider trades. Here's a look at the most significant inside sales and purchases filed with the SEC on Thursday, July 11, 2013.

Notable Purchases:
  • QVT Associates GP LLC bought 390,944 shares of infectious diseases-focused pharmaceutical company Achillion Pharmaceuticals (NASDAQ:ACHN) stock for $2,475,223.
  • Kent McCarthy, the Founder and CEO of Jayhawk Capital Management, which specializes in Asian equities, bought 366,782 shares of Chinese umbilical cord blood storage and stem cell processing company China Cord Blood (NYSE:CO) for $1,066,639.
  • At medical diagnostic imaging systems company Digirad (NASDAQ:DRAD), Director Jeffrey Eberwein bought 15,000 shares of company stock for $36,433 while his fellow Director Charles Gillman also bough 15,000 shares, but for $36,426.
Notable Sales:
  • Francis Bong, a Director of AECOM Technology (NYSE:ACM), sold 80,000 shares of company stock for $2,570,000.
For more insider trades, see the charts below.

Insider Purchases
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1
BO
B
$2,475,223
2
BO
B
$1,066,639
3
BO
JB*
$237,141
4
PR,DIR,BO
JB*
$115,000
5
O
B
$106,266
6
CEO,CB,BO
B
$72,088
7
DIR
AB
$36,433
8
DIR
AB
$36,426
9
DIR
B
$18,220
10
DIR,BO
B
$13,000

Insider Sales
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1
CEO,DIR,BO
AS
$56,786,968
2
COO,DIR
AS
$4,526,760
3
DIR
S
$3,209,864
4
DIR
AS
$2,570,000
5
DIR
AS
$1,395,190
6
CEO,DIR,BO
S
$1,097,554
7
DIR
S
$1,032,915
8
DIR,BO
AS
$982,169
9
O
S
$968,399
10
PR
AS
$877,500

Source: InsiderInsights.com | Key to Insider Title and Trans Type Codes

An important note from Jonathan Moreland, founder of Insider Insights:

In a victory for common sense, it has been proven profitable -- by both academic studies and (more importantly) the experience of your fellow professional investors -- to monitor the trading behavior of company executives, directors, and large shareholders in the stocks of firms of which they're registered as "insiders."

Please note, however, that the lists above are strictly factual; they are not buy and sell recommendations. Dollar value is only one metric to assess the importance of an insider transaction, and, frankly, often not even the most important metric that determines if an insider transaction is significant.

At InsiderInsights.com, we find new investment ideas just about every day using these and more intricate insider screens to determine where we should focus our subsequent fundamental and technical analysis. And while stocks don't (or shouldn't) move up or down based on insider activity alone, insiders tend to be good indicators of when real stock-moving events like earnings surprises, corporate actions, and new products may be in the offing.

Jonathan Moreland is also the author of "Profit From Legal Insider Trading."
No positions in stocks mentioned.
PrintPRINT

Busy? Subscribe to our free newsletter!

Submit
 

WHAT'S POPULAR IN THE VILLE